Thirty-one patients with primary hepatocellular carcinoma survived for more than 5 years after hepatectomy

Hepatobiliary and Pancreatic Diseases International

Volumn 1, Issue 2, 2002, Pages 191-193

  Zhou, Dong Hui ^a   Feng, Yi Zhen ^a   Zhao, Wen He ^a   Ma, Zhi Ming ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

5 year survival rate; Primary hepatocellular carcinoma; Prognosis; Surgery

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; EARLY DIAGNOSIS; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS; TUMOR VOLUME;

ADULT; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0038544523     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Li LD, Lu FZ, Zhang SW, et al. Analyses of variation trend and short term detection of Chinese malignant tumor mortality during twenty years. Chin J Oncol 1997;19:3-9.
2. Zhou XD, Tang ZY, Yu YQ, et al. Changing prognosis of primary liver cancer: some aspects to improve long-term survival. Chin J Oncol 1996;18:211-213.
3. Tang ZY (ed). Contemporary oncology. 1st ed. Shanghai: Shanghai Medical University Press. 1993, 561.
4. The Ministry of Health of the People's Republic of China (ed). The regular standards of diagnosis and therapy of the common malignant tumor in China (liver), 2nd ed. Beijing: Beijing Medical University and Chinese Academy of Medical Science Press. 1991,27.
5. Oka H, Tamori A, Kuroki T, et al. Prospective study of α-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 1994;19:61-66.
6. Cong WM, Wu MC, Cheng H, et al. Clinicopathologic features of small hepatocellular carcinoma. Chin J Oncol 1993;15:372-374.
7. Okamoto E, Kyo A, Yamanaka N, et al. Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery 1984; 95: 586-592.
8. Lee CS, Sung JC, Hwang LY, et al. Surgical treatment of 109 patients with symptomatic and asymptomatic hepatocelluar carcinoma. Surgery 1986;99:481-490.
9. Zhou XD, Tang ZY, Yu YG, et al. Long-term survivors after resection for primary liver cancer. Cancer 1989: 63: 2201-2206.
10. Masutani S, Sasaki Y, Iwamoto S, et al. The prognostic significance of surgical margin in liver resection of patients with hepatocellular carcinoma. Arch Surg 1994;129:1025-1030.